Core Viewpoint - Geron Corporation is facing a class action lawsuit due to allegations of misleading statements regarding the growth potential of its drug Rytelo (imetelstat), leading to a significant drop in stock price after disappointing financial results were announced [2][4]. Summary by Sections Class Action Details - The class period for the lawsuit is from February 28, 2024, to February 25, 2025 [2]. - Allegations include that Geron provided investors with overly optimistic expectations about Rytelo's market potential while downplaying risks associated with its monitoring requirements and competition [2]. Financial Impact - On February 26, 2025, Geron reported that Rytelo's growth had flattened, attributing this to seasonality, competition, lack of awareness, and monitoring burdens [2]. - Following this announcement, Geron's stock price plummeted from $2.37 per share on February 25, 2025, to $1.61 per share on February 26, 2025, marking a decline of approximately 32.07% in one day [2]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by May 12, 2025, to potentially become lead plaintiffs [3]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the case's progress [3]. Law Firm Background - The Gross Law Firm specializes in class action lawsuits and aims to protect investors from deceit and fraud [4]. - The firm emphasizes the importance of responsible business practices and seeks recovery for investors affected by misleading statements [4].

Core Viewpoint - Neumora Therapeutics, Inc. is facing a class action lawsuit due to allegations of issuing misleading statements regarding its clinical trials and the efficacy of its flagship therapeutic candidate, Navacaprant [2][3]. Group 1: Allegations - The lawsuit claims that Neumora amended the original Phase Two trial inclusion criteria to include patients with moderate to severe Major Depressive Disorder (MDD) to justify its Phase Three Program [2]. - It is alleged that the company added a prespecified analysis to the Phase Two statistical analysis plan, focusing on patients suffering from moderate to severe MDD [2]. - The complaint also states that the Phase Two Trials lacked adequate data, particularly concerning the patient population size and the male-to-female ratio, which could affect the predictability of the KOASTAL-1 study results [2]. Group 2: Class Action Details - The class period for the lawsuit commenced on or about September 15, 2023, and shareholders are encouraged to register by April 7, 2025, to participate [1][3]. - Shareholders who register will be enrolled in a portfolio monitoring software to receive updates throughout the case lifecycle [3]. - There is no cost or obligation for shareholders to participate in the case [3]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [4].

NEW YORK, April 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Quantum Computing Inc. (NASDAQ: QUBT).Shareholders who purchased shares of QUBT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/quantum-computing-inc-loss-submission-form/?id=140397&from=4CLASS PERIOD: March 30 ...

Core Viewpoint - Zynex, Inc. is facing allegations of issuing materially false and misleading statements, leading to potential legal consequences and financial repercussions for the company [1]. Allegations Summary - The complaint alleges that Zynex shipped products, including electrodes, in excess of need, inflating its revenue [1]. - The company's practice of filing false claims has drawn scrutiny from insurers, including the U.S. military health insurance program, Tricare [1]. - As a result of these practices, Zynex is likely to face adverse consequences, including removal from insurer networks and penalties from the federal government [1]. - The positive statements made by the defendants regarding the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [1]. Class Action Details - The class period for the allegations is from March 13, 2023, to March 11, 2025 [1]. - Shareholders are encouraged to register for the class action by May 19, 2025, to participate in potential recovery [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software for status updates throughout the case [2]. Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (NASDAQ: ZYXI). Shareholders who purchased shares of ZYXI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form/?id=139462&from=3 CLASS PERIOD: March 13, 2023 to Marc ...

Core Points - enCore Energy Corp. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements during the class period from March 28, 2024, to March 2, 2025 [3] - The allegations include a lack of effective internal controls over financial reporting, inability to capitalize certain exploratory and development costs under GAAP, and a substantial increase in net losses as a result [3] - The lawsuit claims that the defendants' positive statements about the company's business and prospects were materially misleading and lacked a reasonable basis [3] Shareholder Information - Shareholders who purchased shares during the specified class period are encouraged to register for the class action and can seek lead plaintiff status by the deadline of May 13, 2025 [4] - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [4] - There is no cost or obligation for shareholders to participate in this case [4] Legal Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [5] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that led to artificial inflation of stock prices [5]

Shareholders who purchased shares of MRVI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/maravai-lifesciences-holdings-inc-loss-submission-form/? id=139458&from=3 CLASS PERIOD: August 7, 2024 to February 24, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false ...

Core Viewpoint - The Trade Desk, Inc. is facing a class action lawsuit due to allegations of issuing materially false and misleading statements regarding its AI forecasting tool, Kokai, and its impact on the company's business operations and revenue growth [3][4]. Summary by Sections Allegations - The complaint alleges that during the class period from May 9, 2024, to February 12, 2025, The Trade Desk experienced significant execution challenges in rolling out its AI tool, Kokai, which included difficulties in transitioning clients from the older platform, Solimar [3]. - These execution challenges delayed the Kokai rollout, negatively impacting the company's business operations and revenue growth [3]. - As a result, the positive statements made by the company regarding its business and prospects were deemed materially false and misleading [3]. Class Action Details - Shareholders who purchased shares of The Trade Desk during the specified class period are encouraged to register for the class action, with a deadline set for April 21, 2025 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [4]. Law Firm Information - The Gross Law Firm, which is leading the class action, is recognized for protecting investors' rights against deceit and fraud, aiming to ensure responsible business practices [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of FMC Corporation regarding a class action lawsuit due to alleged misleading statements and failure to disclose critical information during a specified class period [1][3]. Summary by Sections Class Period and Allegations - The class period for the lawsuit is from November 16, 2023, to February 4, 2025 [3]. - Allegations include: 1. The company's channel management initiatives were not progressing as claimed [3]. 2. The company chose not to compete on prices due to pricing pressure, resulting in missed sales opportunities [3]. 3. There was inflated inventory in channels across Latin America, Asia, Canada, and Eastern Europe [3]. 4. Positive statements made by the defendants regarding the company's business and prospects were materially misleading [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by April 14, 2025, to participate in potential recovery [4]. - Registration includes enrollment in a portfolio monitoring software for status updates throughout the case [4]. Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Monolithic Power Systems Inc. regarding a class action lawsuit due to alleged misleading statements and quality control issues affecting the company's products [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from February 8, 2024, to November 8, 2024 [3]. - Allegations include that Monolithic's voltage regulator modules and power management integrated circuits experienced significant performance and quality control issues [3]. - These defects reportedly impacted the performance of products from Monolithic's largest customer, Nvidia, and the relationship between Monolithic and Nvidia has been irreparably damaged [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by April 7, 2025, to potentially become lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case [4]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].